Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002681591 | SCV002992444 | pathogenic | Myasthenic syndrome, congenital, 22 | 2022-04-18 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu60Valfs*13) in the PREPL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PREPL are known to be pathogenic (PMID: 24610330, 28726805, 29913539). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with PREPL-related conditions. This variant is not present in population databases (gnomAD no frequency). |